News

View all
Thumbnail image for CRT Pioneer Fund invests in BCL6 project

CRT Pioneer Fund invests in BCL6 project

The Cancer Research Technology Pioneer Fund is making its ninth investment in a project aiming to develop a new class of therapies for patients with diffuse large B-cell lymphoma - a sub-type of Non-Hodgkin Lymphoma (NHL).

9th December 2016

Thumbnail image for EU expands use of Novartis’ eye drug Lucentis

EU expands use of Novartis’ eye drug Lucentis

The treatment scope of Novartis' Lucentis has been expanded in Europe to include patients with visual impairment due to choroidal neovascularization (CNV) associated with causes other than neovascular age-related macular degeneration (nAMD), or secondary to pathologic myopia (PM).

8th December 2016

Web Exclusives

View all
Thumbnail image for The bigger picture

The bigger picture

Delivering the maximum possible benefits to the NHS does not necessarily mean minimising prices, finds a new report

Webinars

View all

Designing Pharma organisations for success

Across all industries, people are changing the ways they engage with products, services, and brands. View more...

Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download